Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2017 |
| Author/s |
author: Richard Kaplan Linos Vandekerckhove Marcelo Wolff James H McMahon Christine Katlama Paul E Sax Sharon Walmsley Yazdan Yazdanpanah Jean-Michel Molina |
| Publication date | September 11, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |